Factors Involved in Endothelial Dysfunction Related to Angiogenic Disbalance and Oxidative Stress, in Women at High Risk of Term Pre-Eclampsia
Open Access
- 21 July 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (7) , 1409
Abstract
Oxidative and inflammatory stress, angiogenic imbalance, and endothelial dysfunction are pathophysiological mechanisms occurring in pre-eclampsia (PE) that may persist over time and predispose women to a higher risk of cardiovascular disease (CVD) in the future. However, there is little evidence on the vascular function of women at risk of PE who have not developed the disease. The main objective of this research is to study factors and biomarkers involved in endothelial dysfunction related to oxidative stress, angiogenic disbalance, and inflammation in women at high risk of term PE who do not develop the disease. An observational, analytical, retrospective, and descriptive study was carried out in a selected sample of 68 high-risk and 57 non-risk of term PE participants in the STATIN study (FFIS/2016/02/ST EUDRACT No: 2016-005206-19). A significant increase in mean arterial pressure (MAP) levels and oxidative stress biomarkers (uric acid, homocysteine, and total serum antioxidant capacity) was found. Biomarkers of inflammation (interleukin-6 and growth differentiation factor 15) and endothelial function (asymmetric dimethylarginine) were significantly elevated in the group at risk of pre-eclampsia. A significative dependence relationship was also established between MAP and interleukin-6 and uric acid. These results suggest that women at high risk of term PE may represent pregnancies with pre-existing maternal risk factors for CVD, manifested by the own cardiovascular overload of pregnancy. A better understanding of maternal cardiovascular function in pregnancy would allow the improved prediction of CVD late in life in women.Keywords
Funding Information
- Universidad de Murcia (R-832-2019)
This publication has 38 references indexed in Scilit:
- Cardiovascular Disease Risk Factors After Early-Onset Preeclampsia, Late-Onset Preeclampsia, and Pregnancy-Induced HypertensionHypertension, 2015
- Molecular mechanisms of maternal vascular dysfunction in preeclampsiaTrends in Molecular Medicine, 2015
- 2-Methoxyestradiol Plasma Levels Are Associated With Clinical Severity Indices and Biomarkers of PreeclampsiaReproductive Sciences, 2015
- Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension arrayBMC Immunology, 2010
- Role of oxidative stress in the pathogenesis of preeclampsiaArchives of Gynecology and Obstetrics, 2010
- Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsiaArchives of Gynecology and Obstetrics, 2009
- Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analysesAmerican Heart Journal, 2008
- Plasma Homocysteine in Late Pregnancies Complicated with Preeclampsia and in NewbornsAmerican Journal of Perinatology, 2005
- Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectivesJournal of Perinatal Medicine, 1996
- Underlying disorders associated with severe early-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995